PKCδ-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs

The tyrosine kinase inhibitors (TKIs) targeting epidermal growth factor receptor (EGFR) have been widely used for non-small cell lung cancer (NSCLC) patients, but the development of acquired resistance remains a therapeutic hurdle. The reduction of glucose uptake has been implicated in the anti-tumo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncogene
Egile Nagusiak: Chen, Chia-Hung, Wang, Bo-Wei, Hsiao, Yu-Chun, Wu, Chun-Yi, Cheng, Fang-Ju, Hsia, Te-Chun, Chen, Chih-Yi, Wang, Yihua, Weihua, Zhang, Chou, Ruey-Hwang, Tang, Chih-Hsin, Chen, Yun-Ju, Wei, Ya-Ling, Hsu, Jennifer L., Tu, Chih-Yen, Hung, Mien-Chie, Huang, Wei-Chien
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8298203/
https://ncbi.nlm.nih.gov/pubmed/34155348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-021-01889-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak